Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
10021038--HYPONATREMIA^ 10047700--VOMITING 10/4/24 1240 patient received COVID and Influenza vaccine within the past two days and notes headache and nausea with some vomiting of bile this morning. Reports he work up nauseated, vomited and then consumed ice cream and yogurt around 0600 this morning. He denies any ongoing vomiting, fever, chills, abdominal pain, tremors. Blood sugar this morning was reported as 155. VS are WNL. 10/5/24 0331 (S) Situation patient reporting severe nausea without emesis (dry heaving) and requesting relief. PRN anti-emetic not effective. (B) Background patient reports side effects from recent covid vaccine received. (A) Assessment Nursing and medical intervention provided no relief. (R) Recommendations MOD ordered alternative anti-emetic. Nursing staff to monitor for interactions. Patient was hospitalized at Hospital ( 10/5/2024 - 10/8/2024) with hyponatremia (dx per patient Nephrologist on 10/5/2024 9:56 AM at hospital) related to his venlafexine. This was discontinued and patient was placed on Welbutrin. Oct 08, 2024@13:19:59 pharmacist entered allergy into system. Sodium levels were monitored closely upon return to CLC.
10021038--HYPONATREMIA^ 10047700--VOMITING
Venlafaxine HCL